Zhejiang Medicine Co., Ltd. (600216.SS) announced a profit for first quarter that Dropped, from last year
The company's bottom line came in at RMB287.012 million, or RMB0.30 per share. This compares with RMB409.085 million, or RMB0.43 per share, last year.
The company's revenue for the period fell 2.9% to RMB2.190 billion from RMB2.255 billion last year.
Zhejiang Medicine Co., Ltd. earnings at a glance (GAAP) :
-Earnings: RMB287.012 Mln. vs. RMB409.085 Mln. last year.-EPS: RMB0.30 vs. RMB0.43 last year.-Revenue: RMB2.190 Bln vs. RMB2.255 Bln last year.
For comments and feedback contact: editorial@rttnews.com
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.